OncoCyte (NASDAQ:OCX) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a report published on Monday morning. The firm issued a sell rating on the stock. OCX has been the topic of a number of other reports. Stephens restated an “equal weight” rating and set a $4.00 target price on shares of OncoCyte in […]
StockNews.com initiated coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a report published on Monday morning. The firm issued a sell rating on the stock. OCX has been the topic of a number of other reports. Stephens restated an “equal weight” rating and set a $4.00 target price on shares of OncoCyte in […]
